Rokahr K L, Sharland A F, Sun J, Wang C, Sheil A G, Yan Y, McCaughan G W, Bishop G A
A. W. Morrow Gastroenterology and Liver Laboratory, Centenary Institute, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia,
Immunology. 1998 Oct;95(2):257-63. doi: 10.1046/j.1365-2567.1998.00840.x.
Liver allografts in many animal models are often spontaneously accepted across a complete histocompatibility barrier without requirement for immunosuppression. In contrast, skin allografts are usually rejected, even across minor histocompatibility barriers. To identify the mechanism of liver allograft acceptance we have compared skin rejection with liver acceptance in DA rat strain recipients of PVG donors, a major histocompatibility complex (MHC) class I plus II mismatch. In spite of the established role of draining lymph nodes (LN) in induction of rejection of skin allografts, there was much greater involvement of LN after liver than after skin transplantation. Few donor cells migrated to these organs from transplanted skin but many cells migrated from transplanted liver. There was also a paradoxical increase in interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) mRNA in LN and spleen of liver allograft recipients that greatly exceeded their expression in skin allograft recipients. For example, there were 2. 7+/-1.6x104 molecules of IFN-gamma per 106 molecules of beta-actin mRNA in the LN draining liver allografts 1 day after transplantation compared with 2.0+/-0.3x103 molecules/106 beta-actin in LN draining skin allografts and 8.1+/-1.8x102 molecules/106 beta-actin in LN draining skin isografts. Examination of the graft showed that infiltration and cytokine mRNA up-regulation occurred more slowly in the transplanted skin than in liver but progressed inexorably in skin grafts until rejection. These results show that liver acceptance is associated with a paradoxical marked early activation then subsequent decline of the immune response.
在许多动物模型中,肝脏同种异体移植常常能在完全的组织相容性屏障下自发被接受,无需免疫抑制。相比之下,皮肤同种异体移植通常会被排斥,即使跨越次要组织相容性屏障也是如此。为了确定肝脏同种异体移植被接受的机制,我们比较了PVG供体的DA大鼠品系受体中皮肤排斥与肝脏接受情况,这是一种主要组织相容性复合体(MHC)I类和II类不匹配的情况。尽管引流淋巴结(LN)在皮肤同种异体移植排斥诱导中已确立作用,但肝脏移植后LN的参与程度比皮肤移植后要大得多。很少有供体细胞从移植的皮肤迁移到这些器官,但许多细胞从移植的肝脏迁移过来。肝脏同种异体移植受体的LN和脾脏中白细胞介素-2(IL-2)和干扰素-γ(IFN-γ)mRNA也出现了矛盾的增加,大大超过了它们在皮肤同种异体移植受体中的表达。例如,移植后1天,引流肝脏同种异体移植的LN中每106个β-肌动蛋白mRNA分子中有2.7±1.6x104个IFN-γ分子,而引流皮肤同种异体移植的LN中为2.0±0.3x103个分子/106个β-肌动蛋白,引流皮肤同基因移植的LN中为8.1±1.8x102个分子/106个β-肌动蛋白。对移植物的检查表明,移植皮肤中的浸润和细胞因子mRNA上调比肝脏中发生得更慢,但在皮肤移植物中会持续发展直至排斥。这些结果表明,肝脏被接受与免疫反应早期出现矛盾的显著激活然后随后下降有关。